Cargando…

Therapeutic Potency of Nanoformulations of siRNAs and shRNAs in Animal Models of Cancers

RNA Interference (RNAi) has brought revolutionary transformations in cancer management in the past two decades. RNAi-based therapeutics including siRNA and shRNA have immense scope to silence the expression of mutant cancer genes specifically in a therapeutic context. Although tremendous progress ha...

Descripción completa

Detalles Bibliográficos
Autores principales:	Karim, Md. Emranul, Tha, Kyi Kyi, Othman, Iekhsan, Borhan Uddin, Mohammad, Chowdhury, Ezharul Hoque
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2018
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6026921/ https://www.ncbi.nlm.nih.gov/pubmed/29861465 http://dx.doi.org/10.3390/pharmaceutics10020065

Ejemplares similares

Carbonate Apatite Nanoparticles-Facilitated Intracellular Delivery of siRNA(s) Targeting Calcium Ion Channels Efficiently Kills Breast Cancer Cells
por: Uddin, Mohammad Borhan, et al.
Publicado: (2018)

Targeting Cell Adhesion Molecules via Carbonate Apatite-Mediated Delivery of Specific siRNAs to Breast Cancer Cells In Vitro and In Vivo
por: Ashaie, Maeirah Afzal, et al.
Publicado: (2019)

Asymmetrically designed siRNAs and shRNAs enhance the strand specificity and efficacy in RNAi
por: Ding, Hongliu, et al.
Publicado: (2007)

Magnesium Fluoride Forms Unique Protein Corona for Efficient Delivery of Doxorubicin into Breast Cancer Cells
por: Al-Busaidi, Hamed, et al.
Publicado: (2019)

Strontium Sulfite: A New pH-Responsive Inorganic Nanocarrier to Deliver Therapeutic siRNAs to Cancer Cells
por: Karim, Md. Emranul, et al.
Publicado: (2019)

PEGylated Strontium Sulfite Nanoparticles with Spontaneously Formed Surface-Embedded Protein Corona Restrict Off-Target Distribution and Accelerate Breast Tumour-Selective Delivery of siRNA
por: Karim, Md. Emranul, et al.
Publicado: (2022)

Scope and challenges of nanoparticle-based mRNA delivery in cancer treatment
por: Karim, Md. Emranul, et al.
Publicado: (2022)

Generation of shRNAs from randomized oligonucleotides
por: Wu, Hailong, et al.
Publicado: (2007)

α-Ketoglutaric Acid-Modified Carbonate Apatite Enhances Cellular Uptake and Cytotoxicity of a Raf-Kinase Inhibitor in Breast Cancer Cells through Inhibition of MAPK and PI-3 Kinase Pathways
por: Hossain, Sultana Mehbuba, et al.
Publicado: (2019)

Insulin-Loaded Barium Salt Particles Facilitate Oral Delivery of Insulin in Diabetic Rats
por: Zaman, Rahela, et al.
Publicado: (2020)

Towards Antiviral shRNAs Based on the AgoshRNA Design
por: Liu, Ying Poi, et al.
Publicado: (2015)

Carbonate Apatite and Hydroxyapatite Formulated with Minimal Ingredients to Deliver SiRNA into Breast Cancer Cells In Vitro and In Vivo
por: Islam, Rowshan Ara, et al.
Publicado: (2020)

96 shRNAs designed for maximal coverage of HIV-1 variants
por: Mcintyre, Glen John, et al.
Publicado: (2009)

Prediction of ultra-potent shRNAs with a sequential classification algorithm
por: Pelossof, Raphael, et al.
Publicado: (2017)

Intracellular Delivery of siRNAs Targeting AKT and ERBB2 Genes Enhances Chemosensitization of Breast Cancer Cells in a Culture and Animal Model
por: Fatemian, Tahereh, et al.
Publicado: (2019)

Selection of hyperfunctional siRNAs with improved potency and specificity
por: Wang, Xiaowei, et al.
Publicado: (2009)

Anticipating and blocking HIV-1 escape by second generation antiviral shRNAs
por: Schopman, Nick CT, et al.
Publicado: (2010)

Optimized models for design of efficient miR30-based shRNAs
por: Matveeva, Olga V., et al.
Publicado: (2012)

Differential Regulation of Vascular Endothelial Growth Factors by Promoter-targeted shRNAs
por: Laham-Karam, Nihay, et al.
Publicado: (2015)

In vitro Inhibition of Border Disease Virus Replication With Lentivirus-Mediated shRNAs
por: Arani, Mohammad Javad Hajihasani, et al.
Publicado: (2021)

Reversing multidrug resistance in breast cancer cells by silencing ABC transporter genes with nanoparticle-facilitated delivery of target siRNAs
por: Li, Yong Tsuey, et al.
Publicado: (2012)

Identification of tri-phosphatase activity in the biogenesis of retroviral microRNAs and RNAP III-generated shRNAs
por: Burke, James M., et al.
Publicado: (2014)

Polymerase II Promoter Strength Determines Efficacy of microRNA Adapted shRNAs
por: Lebbink, Robert Jan, et al.
Publicado: (2011)

SSD - a free software for designing multimeric mono-, bi- and trivalent shRNAs
por: de Carli, Gabriel José, et al.
Publicado: (2020)

Fe/Mg-Modified Carbonate Apatite with Uniform Particle Size and Unique Transport Protein-Related Protein Corona Efficiently Delivers Doxorubicin into Breast Cancer Cells
por: Haque, Sheikh Tanzina, et al.
Publicado: (2020)

siRNAs Targeting Growth Factor Receptor and Anti-Apoptotic Genes Synergistically Kill Breast Cancer Cells through Inhibition of MAPK and PI-3 Kinase Pathways
por: Kamaruzman, Nur Izyani, et al.
Publicado: (2018)

Many si/shRNAs can kill cancer cells by targeting multiple survival genes through an off-target mechanism
por: Putzbach, William, et al.
Publicado: (2017)

Right- and left-loop short shRNAs have distinct and unusual mechanisms of gene silencing
por: Dallas, Anne, et al.
Publicado: (2012)

Incorporation of aptamers in the terminal loop of shRNAs yields an effective and novel combinatorial targeting strategy
por: Pang, Ka Ming, et al.
Publicado: (2018)

A streamlined method for the design and cloning of shRNAs into an optimized Dox-inducible lentiviral vector
por: Frank, Sander B., et al.
Publicado: (2017)

Design of Synthetic shRNAs for Targeting Hepatitis C: A New Approach to Antiviral Therapeutics
por: Johnston, Brian H., et al.
Publicado: (2012)

Harnessing Intronic microRNA Structures to Improve Tolerance and Expression of shRNAs in Animal Cells
por: Challagulla, Arjun, et al.
Publicado: (2022)

Plasmids Expressing shRNAs Specific to the Nucleocapsid Gene Inhibit the Replication of Porcine Deltacoronavirus In Vivo
por: Gu, Jun, et al.
Publicado: (2021)

Nanoparticles Targeting Receptors on Breast Cancer for Efficient Delivery of Chemotherapeutics
por: Jahan, Sulltana, et al.
Publicado: (2021)

Anti-LRP/LR specific antibodies and shRNAs impede amyloid beta shedding in Alzheimer's disease
por: Jovanovic, Katarina, et al.
Publicado: (2013)

Inhibition of Hepatitis B Virus and Induction of Hepatoma Cell Apoptosis by ASGPR-Directed Delivery of shRNAs
por: Ma, Jingwei, et al.
Publicado: (2012)

MiRNA-Embedded ShRNAs for Radiation-Inducible LGMN Knockdown and the Antitumor Effects on Breast Cancer
por: Zhang, Zhi-Qiang, et al.
Publicado: (2016)

DROSHA Knockout Leads to Enhancement of Viral Titers for Vectors Encoding miRNA-Adapted shRNAs
por: Park, Hee Ho, et al.
Publicado: (2018)

Lentivirus expressing shRNAs inhibit the replication of contagious ecthyma virus by targeting DNA polymerase gene
por: Asadi Samani, Leila, et al.
Publicado: (2020)

Oncogenic Signaling in Tumorigenesis and Applications of siRNA Nanotherapeutics in Breast Cancer
por: Kamaruzman, Nur Izyani, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_4b7h8fjiruq2gu6nnpme1ive10